230 related articles for article (PubMed ID: 28512017)
1. A case of autoimmune severe acquired von Willebrand syndrome (type 3-like).
Gavva C; Patel P; Shen YM; Frenkel E; Sarode R
Transfus Apher Sci; 2017 Jun; 56(3):431-433. PubMed ID: 28512017
[TBL] [Abstract][Full Text] [Related]
2. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of inhibitors in acquired von Willebrand syndrome.
Mohri H; Motomura S; Kanamori H; Matsuzaki M; Watanabe S; Maruta A; Kodama F; Okubo T
Blood; 1998 May; 91(10):3623-9. PubMed ID: 9572997
[TBL] [Abstract][Full Text] [Related]
4. Systemic lupus erythematosus complicated by acquired von Willebrand's syndrome.
Hong S; Lee J; Chi H; Lee C; Nah S; Kim Y; Oh J; Moon H; Yoo B
Lupus; 2008 Sep; 17(9):846-8. PubMed ID: 18755868
[TBL] [Abstract][Full Text] [Related]
5. Acquired von Willebrand syndrome--report of 10 cases and review of the literature.
Nitu-Whalley IC; Lee CA
Haemophilia; 1999 Sep; 5(5):318-26. PubMed ID: 10583513
[TBL] [Abstract][Full Text] [Related]
6. Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):724-727. PubMed ID: 33618961
[TBL] [Abstract][Full Text] [Related]
7. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):577-88. PubMed ID: 16977568
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome.
Karger R; Weippert-Kretschmer M; Budde U; Kretschmer V
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):144-7. PubMed ID: 21178586
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome.
Stufano F; Boscarino M; Bucciarelli P; Baronciani L; Maino A; Cozzi G; Peyvandi F
Semin Thromb Hemost; 2019 Feb; 45(1):36-42. PubMed ID: 29913537
[TBL] [Abstract][Full Text] [Related]
10. [Acquired immune-mediated von Willebrand syndrome accompanied by antiphospholipid syndrome].
Kobayashi N; Ogawa Y; Yanagisawa K; Ishizaki T; Uchiumi H; Suzuki N; Matsushita T; Ichinose A; Handa H
Rinsho Ketsueki; 2017; 58(6):613-618. PubMed ID: 28679991
[TBL] [Abstract][Full Text] [Related]
11. [Acquired von Willebrand syndrome in a patient with immune thrombocytopenic purpura].
Ihara A; Suzuki N; Matsushita T; Ichinose A
Rinsho Ketsueki; 2015 Jul; 56(7):901-4. PubMed ID: 26256928
[TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand syndrome in congenital heart disease surgery: results from an observational case-series.
Icheva V; Nowak-Machen M; Budde U; Jaschonek K; Neunhoeffer F; Kumpf M; Hofbeck M; Schlensak C; Wiegand G
J Thromb Haemost; 2018 Nov; 16(11):2150-2158. PubMed ID: 29908036
[TBL] [Abstract][Full Text] [Related]
13. Von Willebrand's disease: case report and review of literature.
Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
[TBL] [Abstract][Full Text] [Related]
14. Association of acquired von Willebrand syndrome with AL amyloidosis.
Kos CA; Ward JE; Malek K; Sanchorawala V; Wright DG; O'Hara C; Connors L; Skinner M; Seldin DC
Am J Hematol; 2007 May; 82(5):363-7. PubMed ID: 17205535
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
[TBL] [Abstract][Full Text] [Related]
16. Acquired type 3-like von Willebrand syndrome preceded full-blown systemic lupus erythematosus.
Niiya M; Niiya K; Takazawa Y; Hayashi Y; Tanio Y; Kushiro M; Tanimizu M; Hasegawa H; Tanimoto M
Blood Coagul Fibrinolysis; 2002 Jun; 13(4):361-5. PubMed ID: 12032403
[TBL] [Abstract][Full Text] [Related]
17. Acquired von Willebrand syndrome: data from an international registry.
Federici AB; Rand JH; Bucciarelli P; Budde U; van Genderen PJ; Mohri H; Meyer D; Rodeghiero F; Sadler JE;
Thromb Haemost; 2000 Aug; 84(2):345-9. PubMed ID: 10959711
[TBL] [Abstract][Full Text] [Related]
18. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of acquired von Willebrand syndrome.
Tiede A
Thromb Res; 2012 Dec; 130 Suppl 2():S2-6. PubMed ID: 23439003
[TBL] [Abstract][Full Text] [Related]
20. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome.
Federici AB
Hum Immunol; 2005 Apr; 66(4):422-30. PubMed ID: 15866707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]